Photo from Cancer Research Institute/LinkedIn
May 28, 2024, 03:05
CICON24, an unmissable event for anyone interested in advancing cancer immunotherapy – Cancer Research Institute
Cancer Research Institute (CRI) shared on LinkedIn:
“Abstract submission closes on June 3 for CICON24, an unmissable event for anyone interested in advancing cancer immunotherapy. Submit an abstract today to be part of the conversation shaping the future of cancer treatment! All abstracts will be considered for short oral presentations.”